<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/lopez/grobid/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Association of Bisphenol A Exposure With Hypertension and Early Macrovascular Diseases in Chinese Adults</title>
			</titleStmt>
			<publicationStmt>
				<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
				<availability status="unknown"><p>Copyright Ovid Technologies (Wolters Kluwer Health)</p>
				</availability>
				<date type="published" when="2015-10">2015-10</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>MD</roleName><forename type="first">Tiange</forename><surname>Wang</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Min</forename><surname>Xu</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Yu</forename><surname>Xu</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Jieli</forename><surname>Lu</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Mian</forename><surname>Li</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Yuhong</forename><surname>Chen</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Weiqing</forename><surname>Wang</surname></persName>
						</author>
						<author role="corresp">
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Shenghan</forename><surname>Lai</surname></persName>
							<email>slai@jhmi.edu</email>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Yufang</forename><surname>Bi</surname></persName>
						</author>
						<author>
							<persName xmlns="http://www.tei-c.org/ns/1.0"><roleName>PhD</roleName><forename type="first">Guang</forename><surname>Ning</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Shanghai Clinical Center for Endocrine and Metabolic Diseases</orgName>
								<orgName type="department" key="dep2">Department of Pathology</orgName>
								<orgName type="laboratory" key="lab1">State Key Laboratory of Medical Genomics</orgName>
								<orgName type="laboratory" key="lab2">Key Laboratory for Endocrine and Metabolic Diseases</orgName>
								<orgName type="institution" key="instit1">Ministry of Health</orgName>
								<orgName type="institution" key="instit2">the National Clinical Research Center for Metabolic Diseases</orgName>
								<orgName type="institution" key="instit3">Rui Jin Hospital</orgName>
								<orgName type="institution" key="instit4">Shanghai Jiao Tong University School of Medicine</orgName>
								<address>
									<settlement>Shanghai</settlement>
									<region>TW, MX, YX, JL, ML, YC, WW, YB, GN</region>
									<country>China (</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Johns Hopkins University School of Medicine</orgName>
								<address>
									<settlement>Baltimore</settlement>
									<region>MD</region>
									<country>USA (SL</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department of Endocrine and Metabolic Diseases</orgName>
								<orgName type="department" key="dep2">Shanghai Jiao Tong University School of Medicine</orgName>
								<orgName type="laboratory">Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health</orgName>
								<orgName type="institution">Rui Jin Hospital</orgName>
								<address>
									<addrLine>197 Rui-Jin 2nd Road</addrLine>
									<postCode>200025</postCode>
									<settlement>Shanghai</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department" key="dep1">Department of Pathology</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">Johns Hopkins University</orgName>
								<address>
									<addrLine>600N Wolfe Street, Pathology 301</addrLine>
									<postCode>21287</postCode>
									<settlement>Baltimore</settlement>
									<region>MD</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Association of Bisphenol A Exposure With Hypertension and Early Macrovascular Diseases in Chinese Adults</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Medicine</title>
						<title level="j" type="abbrev">Medicine</title>
						<idno type="ISSN">0025-7974</idno>
						<imprint>
							<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
							<biblScope unit="volume">94</biblScope>
							<biblScope unit="issue">43</biblScope>
							<biblScope unit="page">e1814</biblScope>
							<date type="published" when="2015-10" />
						</imprint>
					</monogr>
					<idno type="DOI">10.1097/md.0000000000001814</idno>
					<idno type="PMID">26512580</idno>
					<idno type="PMCID">PMC4985394</idno>
					<note type="submission">Received: May 13, 2015; revised: September 18, 2015; accepted: September 22, 2015.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.6.2-SNAPSHOT" ident="GROBID" when="2020-08-13T23:08+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
				<p>Bisphenol A (BPA) is an environmental endocrine disruptor that has been associated with cardiovascular outcomes in previous observational studies. We aimed to examine the relationships of urinary BPA levels with hypertension and early macrovascular diseases. This is a cross-sectional study. From June through August 2009, 3246 participants ages 40 years or older were enrolled from Baoshan District, Shanghai, China. Logistic regression modes were used to estimate the odds ratios (ORs) for prevalent risk of hypertension, elevated carotid intima-media thickness (CIMT), arterial stiffness, and peripheral artery disease (PAD) with multivariable adjustment. We also performed stratification analysis by age and sex. The median (interquartile range) for BPA was 0.81 (0.48, 1.45) ng/ mL, which is notably lower than previously reported in the United States and other Western countries. Urinary BPA concentrations were negatively associated with hypertension (multivariable-adjusted OR for the highest versus lowest BPA quartile ¼ 0.61; 95% confidence interval [CI]: 0.46, 0.80), elevated CIMT (OR ¼ 0.64; 95% CI: 0.47, 0.87), and arterial stiffness (OR ¼ 0.62; 95% CI: 0.44, 0.87). The corresponding OR for PAD (60 cases total) was not significant (OR ¼ 0.89; 95% CI: 0.28, 2.80). The negative associations of BPA with hypertension, elevated CIMT, and arterial stiffness were consistent by age and sex stratifications, and were stronger among participants !60 versus &lt;60 years of age, and among women than men. In contrast with previous investigations, our study suggests negative associations of BPA exposure with hypertension and early macrovascular diseases among middle-aged and elderly Chinese. Future investigations are needed to draw more definite conclusions and generalize to other populations. (Medicine 94(43):e1814) Abbreviations: ABI = Ankle-Brachial Index, ba-PWV = brachialankle pulse wave velocity, BPA = bisphenol A, CI = confidence intervals, CIMT = carotid intima-media thickness, DBP = diastolic blood pressure, HDL-C = high-density lipoprotein cholesterol, IQR = interquartile range, LDL-C = low-density lipoprotein cholesterol, OR = odds ratio, PAD = peripheral artery disease, SBP = systolic blood pressure, SD = standard deviation.</p>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>INTRODUCTION</head><p>B isphenol A (BPA) is one of the world's most widely manufactured chemicals, with more than 2.2 million tons produced each year. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b1">2</ref> Human population is widely and continuously exposed to BPA through food, drinking water, dermal exposures and inhalation of dusts. Detectable urinary BPA levels have been found to be present in 93% to 95% of children and adults in national surveys conducted in United States. <ref type="bibr" target="#b2">3,</ref><ref type="bibr" target="#b3">4</ref> BPA is considered as an environmental endocrine disruptor. <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref> Experimental and epidemiological studies have suggested that BPA exposure may be related to diabetes, <ref type="bibr" target="#b6">[7]</ref><ref type="bibr" target="#b7">[8]</ref><ref type="bibr" target="#b8">[9]</ref> cardiovascular disease, <ref type="bibr" target="#b7">8</ref> thyroid disease, <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref> obesity, and insulin resistance. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b12">13</ref> Hypertension is a major public health problem worldwide and is a core risk factor for cardiovascular disease. Macrovascular complications are major target organ damages in hypertension. <ref type="bibr" target="#b13">14</ref> The markers of the deterioration of macrovascular structure and function, such as carotid intima-media thickness (CIMT), brachial-ankle pulse wave velocity (ba-PWV), and Ankle-Brachial Index (ABI), are predictors for cardiovascular disease. <ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b16">[16]</ref><ref type="bibr" target="#b17">[17]</ref> Recent epidemiological studies have reported that higher levels of urinary BPA were associated with hypertension, <ref type="bibr" target="#b18">18,</ref><ref type="bibr" target="#b19">19</ref> cardiovascular disease, <ref type="bibr" target="#b7">8</ref> coronary, and peripheral artery disease (PAD). <ref type="bibr" target="#b20">20,</ref><ref type="bibr" target="#b21">21</ref> Urinary BPA levels in Chinese adults are notably lower than those reported in the United States. <ref type="bibr" target="#b3">4,</ref><ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b22">22</ref> Until recently, no previous study to our knowledge has examined the relationships of urinary BPA levels with hypertension and early macrovascular diseases in Chinese population. The objective of this study was to examine the relationship between urinary BPA levels, a marker of BPA exposure, and hypertension and early macrovascular diseases in Chinese adults.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study Design and Sample</head><p>Study participants were enrolled from Songnan Community in Baoshan District, Shanghai, China, as reported previously. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b23">23</ref> During June and July 2008, 10,185 residents ages 40 years or older participated in a health examination, and were classified into 1 of 3 groups (normal glucose regulation, impaired glucose regulation, and diabetes) according to fasting glucose levels. <ref type="bibr" target="#b8">9</ref> From June to August 2009, we randomly selected 4012 participants from each group, and among these participants, 3455 participants with blood and urine samples available were included in this study. We excluded participants with missing data for urinary BPA concentration (n ¼ 32), hypertension (n ¼ 51), elevated CIMT (n ¼ 14), or arterial stiffness (n ¼ 112), and finally 3246 participants (1295 men and 1951 women) were included in final analysis. All study participants have provided written informed consent. The study protocol has been approved by the Committee on Human Research at Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical and Biochemical Measurements</head><p>Interviews about the sociodemographic characteristics, lifestyle factors, medical history, and family history were conducted by trained personnel. We collected the information on hypertension medication by asking whether the participants have taken any hypertension medications (yes or no). Clinical examinations, including measurements of weight, height, waist circumference, and blood pressure were performed by experienced nurses according to a standard protocol. Body mass index was calculated as weight/height 2 in kg/m 2 . Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were measured using an electronic BP monitor (OMRON Model HEM-752 FUZZY; Omron Company, Dalian, China), on the nondominant arm in a seated position after resting for 10 min. We used the average value of 3 measurements (taken at 5-min intervals) for analysis.</p><p>Consistent with our previously published studies, <ref type="bibr" target="#b10">11</ref> all participants underwent a 75-g oral glucose tolerance test after an overnight fast, and blood samples were collected using BD Vacutainer 1 vacuum blood-collection tubes (BD Company, Shanghai, China) at 0 and 2 hr during the test. Biochemical measurements were performed at the central laboratory in Shanghai Institute of Endocrine and Metabolic Diseases, which is certified by the College of American Pathologists. Blood glucose was measured on an autoanalyzer (ADVIA-1650 Chemistry System, Bayer, Germany) using the glucose oxidase method. Serum lipids (total cholesterol, high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], and triglycerides) and urinary creatinine were measured by an autoanalyzer (ADVIA-1650 Chemistry System). Diabetes was defined as fasting plasma glucose !7.0 mmol/L, or 2-hr oral glucose tolerance test plasma glucose !11.1 mmol/L, or self-reported physician diagnosis of diabetes or current use of antidiabetic medications. Impaired glucose regulation was defined as fasting plasma glucose !6.1 and &lt;7.0 mmol/L, or a 2-hr oral glucose tolerance test plasma glucose !7.8 and &lt;11.1 mmol/L, without a history of diabetes.</p><p>Morning spot urine samples were collected to measure urinary BPA concentration, using Eppendorf 10 mL centrifuge tubes (Eppendorf Company, Shanghai, China) which are made of polypropylene and free of BPA, delivered at 48C immediately and frozen at À808C within 4 hours of collection at the central laboratory. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">11</ref> In order to prevent contaminations, sample processing strictly adhered to the standard operating procedure at the central laboratory in Shanghai Institute of Endocrine and Metabolic Diseases. Urine samples were immediately stored and maintained at À808C during shipping to the Shanghai Institute of Materia Medica, Chinese Academy of Sciences for BPA measurement. None of the urine samples were thawed, refreezed, or aliquoted before measurement. Total (free and conjugated) urinary BPA concentration was measured by liquid chromatography-tandem mass spectrometry. <ref type="bibr" target="#b8">9,</ref><ref type="bibr" target="#b10">11</ref> The lower limit of detection for BPA was 0.30 ng/mL. The detection rate was 88%, and for analysis purpose, we assigned a value of 0.15 ng/ mL for undetectable BPA concentration (N ¼ 386). <ref type="bibr" target="#b22">22</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurements of Early Macrovascular Diseases</head><p>The measurement of CIMT was performed by 1 trained sonographer, using a high-resolution B-mode tomographic ultrasound system (Esaote Biomedica SpA, Genoa, Italy), with a linear 7.5-MHz transducer. <ref type="bibr" target="#b24">24</ref> CIMT was measured on the far wall of the right and left common carotid arteries with 1.5 cm proximal to the bifurcation, and online at the end of diastole as the distance from the leading edge of the first to the second echogenic line, which represent the lumen-intimal interface and the collagen-contained upper layer of tunic adventitia, respectively. We used the greater value of the right and left common CIMT for analysis.</p><p>Participants were asked to have a rest of 10 to 15 min before ba-PWV examination. The ba-PWV was determined by Colin VP-1000 (Model BP203RPE II, form PWV/ABI) as reported previously. <ref type="bibr" target="#b25">25</ref> We used the greater value of the right and left common ba-PWV for analysis.</p><p>For participants with at least 1 arm and weighting &lt;180 kg, supine SBP was measured using Colin VP-1000 (Model BP203RPE II, form PWV/ABI) after participants resting for 10 to 15 min. <ref type="bibr" target="#b25">25</ref> For participants with conditions precluding the measurement of the right arm, left brachial artery SBP was measured. Left and right ABI values were calculated as the ratio of left and right ankle SBP to arm SBP, respectively. The smallest of the left and right ABI values were used in the analysis. It has been demonstrated that patients with ABIs great equal 1.5 are expected to have severe arterial rigidity, <ref type="bibr" target="#b26">26</ref> and in the present study, all participants had ABIs &lt;1.5.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Definitions</head><p>Hypertension was defined as SBP !140 mm Hg and/or DBP !90 mm Hg and/or taking regular antihypertensive medicine. Participants in the highest 10% of CIMT (!0.8 mm) were defined as elevated CIMT. Upper quartile of ba-PWV (!1690 cm/sec) was regarded as arterial stiffness. PAD was defined as ABI &lt; 0.9. <ref type="bibr" target="#b27">27,</ref><ref type="bibr" target="#b28">28</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p>Statistical analysis was performed using SAS 9.2 (SAS Institute, Cary, NC), and P values &lt;0.05 (2-sided) indicated statistical significance. We log 10 transformed variables with a skewed distribution to achieve a normal distribution. Basic characteristics were presented as mean AE standard deviation (SD) or median with interquartile range (IQR) for continuous variables depending on normality, or proportions for categorical variables. To test for trend of characteristics across BPA quartiles, BPA was modeled as an ordinal variable coding with regard to its quartiles as 1, 2, 3, and 4. We used linear regression model and logistic regression model to test P values for trend for continuous variables and dichotomous variables, respectively.</p><p>To examine the association of BPA levels with hypertension and early macrovascular diseases, the participants were first categorized into quartiles of urinary BPA concentration, and multivariable logistic regression analyses were then performed to calculate the odds ratios (ORs) and corresponding 95% confidence intervals (CIs) of hypertension and early macrovascular diseases for each quartile of BPA with the lowest quartile as the reference group. Potential confounding factors were controlled for in multivariable logistic regression analyses, including age, sex, and urinary creatinine, which are closely related to the exposure levels and metabolism of BPA; and body mass index, waist circumference, smoking and alcohol drinking (never, former, or current), and education attainment ( 6, 6.1-8.9, or !9 years), which are known risk factors for the outcomes. A sensitivity analysis was performed with further adjusting for potential intermediates or consequences of the outcome, including total cholesterol, LDL-C, HDL-C, triglycerides, and diabetes status (normal glucose regulation, impaired glucose regulation, or diabetes) and hypertension treatment (yes or no). <ref type="table" target="#tab_0">Table 1</ref> shows the basic characteristics of study participants according to BPA quartiles. Overall, median age was 58 years (IQR, 52-68 years), and 40% were men. The median urinary BPA level was 0.81 ng/mL (IQR, 0.48-1.45 ng/mL) (data not shown). Compared with other participants, those in the highest BPA quartile were the youngest (on average) and had the highest proportions of men, current smokers, and current alcohol drinkers, and had the highest proportion with high education attainment (!9 years). Compared with participants in the lowest BPA quartile, those in higher quartiles had higher levels of body mass index and waist circumference, lower proportion of hypertension medication, and lower levels of SBP, ba-PWV, CIMT, HDL-C, and urinary creatinine.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head><p>As shown in <ref type="figure" target="#fig_0">Figure 1</ref>, the prevalence of hypertension, elevated CIMT, and arterial stiffness gradually decreased from the first quartile to the third, but was similar between the third and fourth quartiles. The prevalence of PAD was highest among participants in the second BPA quartile, and no clear linear association was observed for BPA quartiles and PAD. After controlling for potential confounding factors, compared with participants in the lowest quartile, those in the highest quartile had a significantly lower prevalence of hypertension (OR ¼ 0.61; 95% CI: 0.46, 0.80), elevated CIMT (OR ¼ 0.64; 95% CI: 0.47, 0.87), and arterial stiffness (OR ¼ 0.62; 95% CI: 0.44, 0.87) ( <ref type="table" target="#tab_1">Table 2)</ref>. BPA also was negatively associated with Data are mean AE SD or median (interquartile range) for continuous variables or number (proportion) for categorical variables. To test P values for trend of characteristics across BPA quartiles, BPA was modeled as an ordinal variable coding with regard to its quartiles as 1, 2, 3, and 4. Continuous variables were examined using univariable linear regression model, and univariable logistic regression model was used for dichotomous characteristics, such as sex, high education attainment (!9 years), current smoker, and current alcohol consumer. BPA ¼ bisphenol A, SD ¼ standard deviation.</p><p>PAD, but there were relatively few cases (60 total) and estimates were imprecise (for the fourth vs first quartile, OR ¼ 0.89; 95% CI: 0.28, 2.80). The associations between BPA and hypertension and macrovascular diseases were in dose-response manner (all P for trend &lt;0.05), except for the relationship with PAD. In the sensitivity analysis, we further adjusted potential intermediate variables, including total cholesterol, LDL-C, HDL-C, log 10 (triglycerides), diabetes status, and hypertension medication, and the associations were not substantially changed ( <ref type="table" target="#tab_1">Table 2)</ref>.</p><p>Considering that urinary BPA concentration varied between men and women (median value of urinary BPA concentration: men, 0.90 [IQR, 0.56, 1.61] vs women, 0.76 [0.43, 1.34], P &lt; 0.0001) and according to age (median value of urinary BPA concentration: age &lt;60 years, 0.90 [IQR, 0.55, 1.57] vs age !60 years, 0.71 [IQR, 0.41, 1.26], P &lt; 0.0001), we further investigated the associations between BPA and hypertension and early macrovascular diseases by age and sex stratifications. Associations of each 1-SD increase in urinary BPA with hypertension and early macrovascular diseases, stratified by age and sex are presented in <ref type="table" target="#tab_2">Table 3</ref>. The negative association of BPA with hypertension and elevated CIMT was stronger in magnitude for older (hypertension: OR ¼ 0.61; 95% CI: 0.43, 0.86; elevated CIMT: OR ¼ 0.53; 95% CI: 0.39, 0.72) versus younger (hypertension: OR ¼ 0.73; 95% CI: 0.53, 1.00; elevated CIMT: OR ¼ 0.85; 95% CI: 0.50, 1.46), and with elevated CIMT and arterial stiffness were stronger in women (elevated CIMT: OR ¼ 0.58; 95% CI: 0.39, 0.87; arterial stiffness: OR ¼ 0.56; 95% CI: 0.38, 0.82) versus men (elevated CIMT: OR ¼ 0.71; 95% CI: 0.49, 1.02; arterial stiffness: OR ¼ 0.62; 95% CI: 0.39, 1.00), but the differences between stratum-specific estimates were not statistically significant (all P for interactions !0.05). There were relatively few cases (60 total) of PAD, and the differences between sex or age strata were not statistically significant.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p>In the present study, we found that urinary BPA levels were negatively associated with the prevalence of hypertension and early macrovascular diseases in 3246 middle-aged and elderly Chinese. The associations remained even after adjusting for potential confounding factors, intermediates, and potential consequences of the outcome.</p><p>Previous studies have reported that urinary BPA concentrations were positively associated with self-reported heart disease in National Health and Nutrition Examination Survey (NHANES) 2003 to 2004 and NHANES 2005 to 2006, after adjusting for traditional risk factors. <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b20">20</ref> Recently, several epidemiological studies have suggested positive associations between urinary BPA levels and hypertension, <ref type="bibr" target="#b18">18,</ref><ref type="bibr" target="#b19">19</ref> cardiovascular disease, 8 coronary arterial disease, and PAD. <ref type="bibr" target="#b20">20,</ref><ref type="bibr" target="#b21">21</ref> Most of studies above-mentioned were conducted in western populations, except for 1 Korean study. <ref type="bibr" target="#b18">18</ref> Bae et al reported a positive nonlinear dose-response association between urinary BPA and hypertension in 258 participants !60 years of age who did not report previous history of hypertension. The concentrations of urinary BPA (median value, 0.81 ng/mL; IQR, 0.48-1.45 ng/ mL) in the present study were low relative to concentrations in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort study (median value, 1.3 ng/mL), <ref type="bibr" target="#b20">20</ref> which reported a positive association between BPA and coronary artery disease in a dose-response manner in a longitudinal analysis. Urinary BPA concentrations in our study population also were lower than concentrations reported for other recent study populations (available median values range from 1.20 to 2.30 ng/mL, available mean values range from 1.79 to 6.93 ng/mL). <ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b18">[18]</ref><ref type="bibr" target="#b19">[19]</ref><ref type="bibr" target="#b20">[20]</ref><ref type="bibr" target="#b21">[21]</ref><ref type="bibr" target="#b29">29</ref> Different from the Korean study, in the present study, the associations between BPA and hypertension, elevated CIMT and arterial stiffness were negative and in doseresponse relationship. The most current study by Bae and Hong reported that consuming canned beverage and consequent increase of BPA exposure increased blood pressure acutely in 60 participants (56 women and 4 men) ages 60 years or older. It is an interesting study revealing a relationship between shortterm BPA exposure and acute effect on blood pressure. <ref type="bibr" target="#b30">30</ref> The association of chronic BPA exposure with cardiovascular risk is still to be evaluated in further longitudinal study.</p><p>BPA is suspected to have a variety of effects in humans, and its estrogenic action is considered to be 1 of the major mechanisms. <ref type="bibr" target="#b31">31</ref> Estrogen has several important effects on the cardiovascular system. <ref type="bibr" target="#b32">32</ref> Estrogen alters the expression or activity of ion channels, contractile proteins, and reactive oxygen species production and all of which may contribute to cardiovascular health. <ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref><ref type="bibr" target="#b34">[34]</ref> It is well-documented that estrogen improves vascular function and reduces atherosclerosis. <ref type="bibr" target="#b32">32</ref> Experimental studies of mice have indicated that the atheroprotection is mediated by estrogen receptor-a and b, <ref type="bibr" target="#b35">35,</ref><ref type="bibr" target="#b36">36</ref> which have important roles in repairing blood vessels and controlling blood pressure. <ref type="bibr" target="#b31">31,</ref><ref type="bibr" target="#b36">36</ref> Estrogen is also important for maintaining and repairing the endothelium. This process appears to involve an estrogen mediated increase in endothelial nitric oxide synthase and cyclooxygenase. <ref type="bibr" target="#b34">34</ref> In humans, the incidence of cardiovascular disease differs widely among men and women, partly because of the variations in hormones. <ref type="bibr" target="#b37">37</ref> Studies have found that the incidence of cardiovascular disease is usually low in premenopausal women and tends to increase in postmenopausal women, however, in postmenopausal women who receive estrogen therapy, the incidence can be reduced to premenopausal levels. <ref type="bibr" target="#b37">[37]</ref><ref type="bibr" target="#b38">[38]</ref><ref type="bibr" target="#b39">[39]</ref> Thus it is biologically possible that exogenous estrogen may have protective effects on hypertension and early macrovascular diseases.</p><p>The exact mechanisms by which BPA exposure may affect the cardiovascular system are not fully understood. Experimental studies of rats and in vitro reported that BPA affects cardiovascular system mainly through inducing liver and oxidative cellular damage, <ref type="bibr" target="#b40">40</ref> disrupting pancreatic b-cell function, <ref type="bibr" target="#b4">5</ref> and promoting obesity and insulin resistance. <ref type="bibr" target="#b5">6</ref> Although hypertension and early macrovascular diseases are risk factors for cardiovascular disease, experimental evidence of mice and in y Sensitivity analysis was further controlled for total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, log 10 (triglycerides), diabetes status, and hypertension medication, based on multivariable-adjusted model. vitro suggested that BPA also acts on cardiovascular system through a series of other ways, including inducing obesity, diabetes, and hormone and lipids dysfunctions. <ref type="bibr" target="#b4">5,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b9">10</ref> Furthermore, it has been suggested that the actions of estrogen and its receptors in the cardiovascular system differ by sex and age. <ref type="bibr" target="#b37">37,</ref><ref type="bibr" target="#b41">41</ref> In the present study, we observed that negative association of BPA with elevated CIMT were stronger in magnitude among those !60 versus &lt;60 years of age. Although it is plausible to speculate that as an exogenous estrogen, BPA may affect the cardiovascular system by mimicking estrogen, future research is needed to give a more clear demonstration on behavior of BPA in humans.</p><p>The strength of the present study included the large sample size, and the understudied population. The present study has several limitations. Firstly, due to the cross-sectional nature of the study, we cannot establish that BPA exposure precedes hypertension and early macrovascular diseases. Longitudinal studies are needed to clarify the chronic effect of BPA exposure on health outcomes. Secondly, we did not collect data on diet behavior, and the specific hypertension medication categories or dose. Thus, confounding by diet or medication cannot be ruled out. Thirdly, the BPA measures are from single spot urine samples, repeated measurements over weeks, months, or even years would improve the evaluation of a long-term exposure. Mahalingaiah et al <ref type="bibr" target="#b42">42</ref> measured urinary BPA concentrations in 217 samples collected over weeks to months from 82 participants attending a fertility clinic in the United States. The authors reported that 63% of participants classified into the highest tertile of the geometric mean concentration of all samples would have been correctly classified based on a single urine sample. Fourthly, due to a generally lower level of BPA exposure in this population, it might be less likely to detect any possibly positive association between BPA and cardiovascular risk than in a population with a wider range of possible exposure levels. Fifthly, our study participants were restricted to middle-aged and elderly Chinese population. Therefore, age, race, and the BPA exposure levels should be considered when generalizing the findings to other populations. Further studies in prospective cohorts are warranted to verify our findings in other demographic or ethnic populations.</p><p>In contrast with previously published studies, our study suggested negative relationships between BPA exposure and hypertension, elevated CIMT, and arterial stiffness in middleaged and elderly Chinese adults. Much about the actions of BPA on cardiovascular functions in humans remain unknown, and well-designed longitudinal studies including a wide range of BPA exposure levels, ages, and genders are imperative for confirming associations and understanding the mechanisms. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIGURE 1 .</head><label>1</label><figDesc>Prevalence (95% confidence interval) of hypertension and early macrovascular diseases across urinary bisphenol A quartiles. (A) Hypertension, P for trend &lt; 0.0001; (B) elevated carotid intima-media thickness (CIMT), P for trend &lt; 0.0001; (C) arterial stiffness, P for trend &lt; 0.0001; and (D) peripheral artery disease (PAD), P for trend ¼ 0.26. Logistic regression model was used to test P values for trend of outcomes across BPA quartiles, and BPA was modeled as an ordinal variable coding with regard to its quartiles as 1, 2, 3, and 4. BPA ¼ bisphenol A.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1 .</head><label>1</label><figDesc>Characteristics of Study Participants</figDesc><table><row><cell></cell><cell></cell><cell cols="2">BPA Quartiles, ng/mL</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Quartile 1</cell><cell>Quartile 2</cell><cell>Quartile 3</cell><cell>Quartile 4</cell><cell>P Value</cell></row><row><cell>Characteristics</cell><cell>( 0.47)</cell><cell>(0.48-0.81)</cell><cell>(0.82-1.45)</cell><cell>(&gt;1.45)</cell><cell>for Trend</cell></row><row><cell>Number</cell><cell>819</cell><cell>806</cell><cell>818</cell><cell>803</cell><cell>-</cell></row><row><cell>Age, yr</cell><cell>62.7 AE 10.2</cell><cell>60.7 AE 9.9</cell><cell>59.0 AE 9.6</cell><cell>58.3 AE 9.6</cell><cell>&lt;0.001</cell></row><row><cell>Male sex, n (%)</cell><cell>255 (31.1)</cell><cell>327 (40.6)</cell><cell>342 (41.8)</cell><cell>371 (46.2)</cell><cell>&lt;0.001</cell></row><row><cell>High education attainment, n (%)</cell><cell>201 (24.9)</cell><cell>215 (26.8)</cell><cell>239 (29.7)</cell><cell>240 (30.3)</cell><cell>&lt;0.001</cell></row><row><cell>Current smoker, n (%)</cell><cell>110 (13.4)</cell><cell>170 (21.1)</cell><cell>176 (21.5)</cell><cell>219 (27.3)</cell><cell>&lt;0.001</cell></row><row><cell>Current alcohol consumer, n (%)</cell><cell>86 (10.5)</cell><cell>135 (16.8)</cell><cell>122 (14.9)</cell><cell>165 (20.6)</cell><cell>&lt;0.001</cell></row><row><cell>Body mass index, kg/m 2</cell><cell>25.3 AE 3.9</cell><cell>25.6 AE 4.1</cell><cell>25.5 AE 3.7</cell><cell>25.5 AE 3.6</cell><cell>0.03</cell></row><row><cell>Waist circumference, cm</cell><cell>86.4 AE 9.8</cell><cell>87.6 AE 9.9</cell><cell>87.2 AE 9.8</cell><cell>87.8 AE 9.7</cell><cell>0.02</cell></row><row><cell>Hypertension medication, n (%)</cell><cell>57 (7.9)</cell><cell>49 (7.0)</cell><cell>53 (7.4)</cell><cell>31 (4.5)</cell><cell>0.02</cell></row><row><cell>Systolic blood pressure, mm Hg</cell><cell>141.8 AE 23.5</cell><cell>139.4 AE 22.4</cell><cell>137.8 AE 21.5</cell><cell>136.1 AE 20.3</cell><cell>&lt;0.001</cell></row><row><cell>Diastolic blood pressure, mm Hg</cell><cell>78.0 AE 10.8</cell><cell>78.2 AE 10.2</cell><cell>78.9 AE 9.9</cell><cell>78.6 AE 10.0</cell><cell>0.15</cell></row><row><cell>Brachial-ankle pulse wave velocity, cm/sec</cell><cell>1602 AE 443</cell><cell>1527 AE 385</cell><cell>1461 AE 343</cell><cell>1453 AE 334</cell><cell>&lt;0.001</cell></row><row><cell>Ankle-Brachial Index</cell><cell>1.12 AE 0.09</cell><cell>1.12 AE 0.10</cell><cell>1.12 AE 0.11</cell><cell>1.12 AE 0.09</cell><cell>0.72</cell></row><row><cell>Carotid intima-media thickness, cm</cell><cell>0.65 AE 0.15</cell><cell>0.64 AE 0.14</cell><cell>0.62 AE 0.13</cell><cell>0.62 AE 0.14</cell><cell>&lt;0.001</cell></row><row><cell>Total cholesterol, mmol/L</cell><cell>5.19 AE 1.04</cell><cell>5.19 AE 0.99</cell><cell>5.13 AE 0.99</cell><cell>5.11 AE 0.94</cell><cell>0.05</cell></row><row><cell>Low-density lipoprotein cholesterol, mmol/L</cell><cell>2.41 AE 0.71</cell><cell>2.38 AE 0.69</cell><cell>2.37 AE 0.70</cell><cell>2.40 AE 0.64</cell><cell>0.67</cell></row><row><cell>High-density lipoprotein cholesterol, mmol/L</cell><cell>1.39 AE 0.33</cell><cell>1.36 AE 0.32</cell><cell>1.34 AE 0.29</cell><cell>1.32 AE 0.29</cell><cell>&lt;0.001</cell></row><row><cell>Triglycerides, mmol/L</cell><cell cols="4">1.42 (1.00, 2.07) 1.44 (0.99, 2.10) 1.47 (1.02, 2.12) 1.46 (1.00, 2.10)</cell><cell>0.27</cell></row><row><cell>Urinary creatinine, mmol/L</cell><cell>77.5 AE 3.7</cell><cell>77.1 AE 3.9</cell><cell>77.1 AE 3.6</cell><cell>76.7 AE 3.8</cell><cell>&lt;0.001</cell></row><row><cell>Diabetes status, n (%)</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Normal glucose regulation</cell><cell>371 (45.3)</cell><cell>376 (46.7)</cell><cell>406 (49.6)</cell><cell>359 (44.7)</cell><cell>0.23</cell></row><row><cell>Impaired glucose regulation</cell><cell>205 (25.0)</cell><cell>160 (19.9)</cell><cell>176 (21.5)</cell><cell>170 (21.2)</cell><cell></cell></row><row><cell>Diabetes</cell><cell>243 (29.7)</cell><cell>270 (33.5)</cell><cell>236 (28.9)</cell><cell>274 (34.1)</cell><cell></cell></row></table><note></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2 .</head><label>2</label><figDesc>Associations of Urinary BPA With Hypertension and Early Macrovascular Diseases</figDesc><table><row><cell></cell><cell></cell><cell cols="2">BPA Quartiles, ng/mL</cell><cell></cell><cell></cell></row><row><cell></cell><cell>Quartile 1</cell><cell>Quartile 2</cell><cell>Quartile 3</cell><cell>Quartile 4</cell><cell>P for</cell></row><row><cell></cell><cell>( 0.47)</cell><cell>(0.48-0.81)</cell><cell>(0.82-1.45)</cell><cell>(&gt;1.45)</cell><cell>Trend</cell></row><row><cell>Hypertension</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Case, %</cell><cell>530 (64.7)</cell><cell>467 (57.9)</cell><cell>436 (53.3)</cell><cell>432 (53.8)</cell><cell></cell></row><row><cell>Age, sex, and urinary creatinine-adjusted Multivariable-adjusted Ã</cell><cell>1.00 1.00</cell><cell>0.85 (0.69, 1.06) 0.71 (0.54, 0.93)</cell><cell>0.77 (0.62, 0.96) 0.66 (0.50, 0.86)</cell><cell>0.86 (0.69, 1.07) 0.61 (0.46, 0.80)</cell><cell>0.12 &lt;0.001</cell></row><row><cell>Elevated carotid intima-media thickness</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Case, %</cell><cell>148 (18.1)</cell><cell>128 (15.9)</cell><cell>96 (11.7)</cell><cell>92 (11.5)</cell><cell></cell></row><row><cell>Age, sex, and urinary creatinine-adjusted Multivariable-adjusted Ã</cell><cell>1.00 1.00</cell><cell>0.89 (0.67, 1.18) 0.89 (0.67, 1.18)</cell><cell>0.69 (0.51, 0.93) 0.67 (0.50, 0.91)</cell><cell>0.69 (0.51, 0.94) 0.64 (0.47, 0.87)</cell><cell>0.005 0.001</cell></row><row><cell>Arterial stiffness</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Case, %</cell><cell>279 (34.1)</cell><cell>209 (25.9)</cell><cell>162 (19.8)</cell><cell>161 (20.1)</cell><cell></cell></row><row><cell>Age, sex, and urinary creatinine-adjusted Multivariable-adjusted Ã</cell><cell>1.00 1.00</cell><cell>0.82 (0.65, 1.05) 0.74 (0.54, 0.99)</cell><cell>0.65 (0.50, 0.83) 0.55 (0.40, 0.77)</cell><cell>0.74 (0.57, 0.95) 0.62 (0.44, 0.87)</cell><cell>0.004 0.001</cell></row><row><cell>Peripheral artery disease</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Case, %</cell><cell>15 (1.8)</cell><cell>20 (2.5)</cell><cell>15 (1.8)</cell><cell>10 (1.3)</cell><cell></cell></row><row><cell>Age, sex, and urinary creatinine-adjusted Multivariable-adjusted Ã</cell><cell>1.00 1.00</cell><cell>1.71 (0.86, 3.40) 1.83 (0.74, 4.53)</cell><cell>1.50 (0.72, 3.14) 1.67 (0.65, 4.29)</cell><cell>1.10 (0.48, 2.49) 0.89 (0.28, 2.80)</cell><cell>0.78 0.94</cell></row><row><cell>Sensitivity analysis y</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Hypertension</cell><cell>1.00</cell><cell>0.72 (0.53, 0.98)</cell><cell>0.61 (0.45, 0.83)</cell><cell>0.60 (0.44, 0.82)</cell><cell>&lt;0.001</cell></row><row><cell>Elevated carotid intima-media thickness</cell><cell>1.00</cell><cell>0.80 (0.59, 1.08)</cell><cell>0.70 (0.51, 0.97)</cell><cell>0.64 (0.46, 0.89)</cell><cell>0.009</cell></row><row><cell>Arterial stiffness</cell><cell>1.00</cell><cell>0.78 (0.56, 1.08)</cell><cell>0.51 (0.35, 0.73)</cell><cell>0.59 (0.41, 0.85)</cell><cell>0.001</cell></row><row><cell>Peripheral artery disease</cell><cell>1.00</cell><cell>1.43 (0.66, 3.11)</cell><cell>1.34 (0.58, 3.10)</cell><cell>0.75 (0.28, 1.99)</cell><cell>0.72</cell></row></table><note>BPA ¼ bisphenol A.Ã Multivariable-adjusted model was adjusted for age, sex, urinary creatinine, body mass index, waist circumference, smoking, alcohol drinking, and education attainment.</note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE 3 .</head><label>3</label><figDesc>Associations of Each 1-SD Increase in Urinary Bisphenol A With Hypertension and Early Macrovascular Diseases, by Age and Sex Stratifications</figDesc><table><row><cell></cell><cell>Sample Size</cell><cell>Multivariable</cell></row><row><cell>Outcome and Group</cell><cell>(Cases)</cell><cell>OR (95% CI)</cell></row></table><note></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="2">| www.md-journal.com Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="6">| www.md-journal.com Copyright # 2015 Wolters Kluwer Health, Inc. All rights reserved.</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hypertension</head><p>Age CI ¼ confidence interval, OR ¼ odds ratio, SD ¼ standard deviation. Each 1-SD of log 10 -transformed urinary bisphenol A (ng/mL) was 0.41.</p><p>Ã Multivariable-adjusted model was adjusted for age, sex, urinary creatinine, body mass index, waist circumference, smoking, alcohol drinking, and education attainment.</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Experts demand European action on plastics chemical</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><surname>Kelland</surname></persName>
		</author>
		<idno>health-idUSTRE65L6JN20100622?loomia_ow¼t0:- t0:s0:a49:g43:r3:c0.084942:b35124310:z0</idno>
		<ptr target="http://www.reuters.com/article/2010/06/22/us-chemical-bpa" />
	</analytic>
	<monogr>
		<title level="j">Reuters</title>
		<imprint>
			<date type="published" when="2010-11-13" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Bisphenol A, CAS No: 80-05-7. Institute for Health and Consumer Protection</title>
	</analytic>
	<monogr>
		<title level="j">European Commission Joint Research Centre</title>
		<imprint>
			<date type="published" when="2003" />
			<publisher>Office for Official Publications of the European Communities</publisher>
		</imprint>
		<respStmt>
			<orgName>European Union. European Union Risk Assessment</orgName>
		</respStmt>
	</monogr>
	<note type="report_type">Report</note>
	<note>European Chemicals Bureau. 3rd Priority List</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Urinary Concentrations of Bisphenol A and 4-Nonylphenol in a Human Reference Population</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonia</forename><forename type="middle">M</forename><surname>Calafat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zsuzsanna</forename><surname>Kuklenyik</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">A</forename><surname>Reidy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Samuel</forename><forename type="middle">P</forename><surname>Caudill</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Ekong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Larry</forename><forename type="middle">L</forename><surname>Needham</surname></persName>
		</author>
		<idno type="DOI">10.1289/ehp.7534</idno>
		<idno type="PMID">15811827</idno>
		<idno type="PMCID">PMC1278476</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1278476?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Health Perspectives</title>
		<title level="j" type="abbrev">Environmental Health Perspectives</title>
		<idno type="ISSN">0091-6765</idno>
		<idno type="ISSNe">1552-9924</idno>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="391" to="395" />
			<date type="published" when="2005-04" />
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Exposure of the U.S. Population to Bisphenol A and 4- tertiary -Octylphenol: 2003–2004</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonia</forename><forename type="middle">M</forename><surname>Calafat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoyun</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lee-Yang</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">A</forename><surname>Reidy</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Larry</forename><forename type="middle">L</forename><surname>Needham</surname></persName>
		</author>
		<idno type="DOI">10.1289/ehp.10753</idno>
		<idno type="PMID">18197297</idno>
		<idno type="PMCID">PMC2199288</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2199288?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Health Perspectives</title>
		<title level="j" type="abbrev">Environmental Health Perspectives</title>
		<idno type="ISSN">0091-6765</idno>
		<idno type="ISSNe">1552-9924</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="39" to="44" />
			<date type="published" when="2008-01" />
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">The Estrogenic Effect of Bisphenol A Disrupts Pancreatic β-Cell Function In Vivo and Induces Insulin Resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Paloma</forename><surname>Alonso-Magdalena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Sumiko</forename><surname>Morimoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Cristina</forename><surname>Ripoll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Esther</forename><surname>Fuentes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angel</forename><surname>Nadal</surname></persName>
		</author>
		<idno type="DOI">10.1289/ehp.8451</idno>
		<idno type="PMID">16393666</idno>
		<idno type="PMCID">PMC1332664</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc1332664?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Health Perspectives</title>
		<title level="j" type="abbrev">Environ Health Perspect</title>
		<idno type="ISSN">0091-6765</idno>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="106" to="112" />
			<date type="published" when="2005-09-20" />
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Bisphenol A at Environmentally Relevant Doses Inhibits Adiponectin Release from Human Adipose Tissue Explants and Adipocytes</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Eric</forename><forename type="middle">R</forename><surname>Hugo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Terry</forename><forename type="middle">D</forename><surname>Brandebourg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jessica</forename><forename type="middle">G</forename><surname>Woo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jean</forename><surname>Loftus</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">Wesley</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nira</forename><surname>Ben-Jonathan</surname></persName>
		</author>
		<idno type="DOI">10.1289/ehp.11537</idno>
		<idno type="PMID">19079714</idno>
		<idno type="PMCID">PMC2599757</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2599757?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Health Perspectives</title>
		<title level="j" type="abbrev">Environmental Health Perspectives</title>
		<idno type="ISSN">0091-6765</idno>
		<idno type="ISSNe">1552-9924</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1642" to="1647" />
			<date type="published" when="2008-12" />
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Ropero</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Alonso-Magdalena</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>García-García</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Ripoll</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Fuentes</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Nadal</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1365-2605.2007.00832.x</idno>
		<idno type="PMID">17971160</idno>
		<idno type="ark">ark:/67375/WNG-NR90WC1D-7</idno>
		<idno type="istexId">6C64204ABC2EAD131234D1877CA1BAB82F44F38F</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Andrology</title>
		<title level="j" type="abbrev">Int J Androl</title>
		<idno type="ISSN">0105-6263</idno>
		<idno type="ISSNe">1365-2605</idno>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="194" to="200" />
			<date type="published" when="2008-04" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Association of Urinary Bisphenol A Concentration With Medical Disorders and Laboratory Abnormalities in Adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Iain</forename><forename type="middle">A</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">S</forename><surname>Galloway</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Scarlett</surname></persName>
		</author>
		<idno type="DOI">10.1001/jama.300.11.1303</idno>
		<idno type="PMID">18799442</idno>
		<ptr type="open-access" target="https://jamanetwork.com/journals/jama/articlepdf/182571/joc80072_1303_1310.pdf" />
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<title level="j" type="abbrev">JAMA</title>
		<idno type="ISSN">0098-7484</idno>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page">1303</biblScope>
			<date type="published" when="2008-09-17" />
			<publisher>American Medical Association (AMA)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Relationship of Urinary Bisphenol A Concentration to Risk for Prevalent Type 2 Diabetes in Chinese Adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Ning</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yufang</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tiange</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mian</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoying</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weiqing</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuhong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yaohua</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jianing</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Aiyun</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shenghan</forename><surname>Lai</surname></persName>
		</author>
		<idno type="DOI">10.7326/0003-4819-155-6-201109200-00005</idno>
		<idno type="PMID">21930854</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of Internal Medicine</title>
		<title level="j" type="abbrev">Ann Intern Med</title>
		<idno type="ISSN">0003-4819</idno>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page">368</biblScope>
			<date type="published" when="2011-09-20" />
			<publisher>American College of Physicians</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenji</forename><surname>Moriyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tetsuya</forename><surname>Tagami</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takashi</forename><surname>Akamizu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Takeshi</forename><surname>Usui</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Misa</forename><surname>Saijo</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Naotetsu</forename><surname>Kanamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuji</forename><surname>Hataya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akira</forename><surname>Shimatsu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hideshi</forename><surname>Kuzuya</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kazuwa</forename><surname>Nakao</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2002-020209</idno>
		<idno type="PMID">12414890</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/87/11/5185/9042151/jcem5185.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="5185" to="5190" />
			<date type="published" when="2002-11" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Urinary Bisphenol A Concentration and Thyroid Function in Chinese Adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tiange</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jieli</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mian</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoguang</forename><surname>Tian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuhong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Meng</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weiqing</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shenghan</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yufang</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Ning</surname></persName>
		</author>
		<idno type="DOI">10.1097/ede.0b013e318280e02f</idno>
		<idno type="PMID">23337242</idno>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<title level="j" type="abbrev">Epidemiology</title>
		<idno type="ISSN">1044-3983</idno>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="295" to="302" />
			<date type="published" when="2013-03" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Urinary bisphenol A and obesity: NHANES 2003–2006</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jenny</forename><forename type="middle">L</forename><surname>Carwile</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Karin</forename><forename type="middle">B</forename><surname>Michels</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.envres.2011.05.014</idno>
		<idno type="PMID">21676388</idno>
		<idno type="PMCID">PMC3747781</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3747781?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Research</title>
		<title level="j" type="abbrev">Environmental Research</title>
		<idno type="ISSN">0013-9351</idno>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="825" to="830" />
			<date type="published" when="2011-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Urinary Bisphenol A (BPA) Concentration Associates with Obesity and Insulin Resistance</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tiange</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Mian</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Bing</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jieli</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yuhong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weiqing</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoying</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yufang</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shenghan</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Guang</forename><surname>Ning</surname></persName>
		</author>
		<idno type="DOI">10.1210/jc.2011-1989</idno>
		<idno type="PMID">22090277</idno>
		<ptr type="open-access" target="https://academic.oup.com/jcem/article-pdf/97/2/E223/10414175/jcemE223.pdf" />
	</analytic>
	<monogr>
		<title level="j">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<title level="j" type="abbrev">The Journal of Clinical Endocrinology &amp; Metabolism</title>
		<idno type="ISSN">0021-972X</idno>
		<idno type="ISSNe">1945-7197</idno>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="E223" to="E227" />
			<date type="published" when="2012-02" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Persistent Macrovascular and Microvascular Dysfunction in Patients With Malignant Hypertension</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Shantsila</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Dwivedi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Shantsila</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Butt</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">G</forename><surname>Beevers</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">Y H</forename><surname>Lip</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.110.166314</idno>
		<idno type="PMID">21263115</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.110.166314" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="490" to="496" />
			<date type="published" when="2011-01-24" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title/>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">D</forename><surname>Murray</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ankle Brachial Index CollaborationFowkes FG</title>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Ankle Brachial Index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis</title>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="197" to="208" />
			<date type="published" when="2008" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthias</forename><forename type="middle">W</forename><surname>Lorenz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Joseph</forename><forename type="middle">F</forename><surname>Polak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maryam</forename><surname>Kavousi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ellisiv</forename><forename type="middle">B</forename><surname>Mathiesen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Henry</forename><surname>Völzke</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomi-Pekka</forename><surname>Tuomainen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Dirk</forename><surname>Sander</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Matthieu</forename><surname>Plichart</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Alberico</forename><forename type="middle">L</forename><surname>Catapano</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Christine</forename><forename type="middle">M</forename><surname>Robertson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Stefan</forename><surname>Kiechl</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tatjana</forename><surname>Rundek</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Moïse</forename><surname>Desvarieux</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lars</forename><surname>Lind</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Caroline</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Pronabesh</forename><surname>Dasmahapatra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lu</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kathrin</forename><surname>Ziegelbauer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Michiel</forename><forename type="middle">L</forename><surname>Bots</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Simon</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0140-6736(12)60441-3</idno>
		<idno type="PMID">22541275</idno>
		<idno type="PMCID">PMC3918517</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3918517?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">The Lancet</title>
		<title level="j" type="abbrev">The Lancet</title>
		<idno type="ISSN">0140-6736</idno>
		<imprint>
			<biblScope unit="volume">379</biblScope>
			<biblScope unit="issue">9831</biblScope>
			<biblScope unit="page" from="2053" to="2062" />
			<date type="published" when="2012-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Brachial-Ankle Pulse Wave Velocity as a Marker of Atherosclerotic Vascular Damage and Cardiovascular Risk</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Akira</forename><surname>Yamashina</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Hirofumi</forename><surname>Tomiyama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tomio</forename><surname>Arai</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ken-Ichi</forename><surname>Hirose</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yutaka</forename><surname>Koji</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoji</forename><surname>Hirayama</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yoshio</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Saburoh</forename><surname>Hori</surname></persName>
		</author>
		<idno type="DOI">10.1291/hypres.26.615</idno>
		<idno type="PMID">14567500</idno>
		<ptr type="open-access" target="https://www.jstage.jst.go.jp/article/hypres/26/8/26_8_615/_pdf" />
	</analytic>
	<monogr>
		<title level="j">Hypertension Research</title>
		<title level="j" type="abbrev">Hypertens Res</title>
		<idno type="ISSN">0916-9636</idno>
		<idno type="ISSNe">1348-4214</idno>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="615" to="622" />
			<date type="published" when="2003" />
			<publisher>Japanese Society of Hypertension</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Associations of Bisphenol A Exposure With Heart Rate Variability and Blood Pressure</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y-H</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><forename type="middle">Y</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y-C</forename><surname>Hong</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.112.197715</idno>
		<idno type="PMID">22851732</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.112.197715" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="786" to="793" />
			<date type="published" when="2012-07-30" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Urinary Bisphenol A and Hypertension in a Multiethnic Sample of US Adults</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anoop</forename><surname>Shankar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Srinivas</forename><surname>Teppala</surname></persName>
		</author>
		<idno type="DOI">10.1155/2012/481641</idno>
		<idno type="PMID">22363351</idno>
		<idno type="PMCID">PMC3272835</idno>
		<ptr type="open-access" target="http://downloads.hindawi.com/journals/jeph/2012/481641.pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Environmental and Public Health</title>
		<title level="j" type="abbrev">Journal of Environmental and Public Health</title>
		<idno type="ISSN">1687-9805</idno>
		<idno type="ISSNe">1687-9813</idno>
		<imprint>
			<biblScope unit="volume">2012</biblScope>
			<biblScope unit="page" from="1" to="5" />
			<date type="published" when="2012" />
			<publisher>Hindawi Limited</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Urinary Bisphenol A Concentration and Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Melzer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Osborne</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">E</forename><surname>Henley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Cipelli</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Money</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Mccormack</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><surname>Luben</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K-T</forename><surname>Khaw</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">J</forename><surname>Wareham</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">S</forename><surname>Galloway</surname></persName>
		</author>
		<idno type="DOI">10.1161/circulationaha.111.069153</idno>
		<idno type="PMID">22354940</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.111.069153" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1482" to="1490" />
			<date type="published" when="2012-02-21" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Bisphenol A and Peripheral Arterial Disease: Results from the NHANES</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anoop</forename><surname>Shankar</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Srinivas</forename><surname>Teppala</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Charumathi</forename><surname>Sabanayagam</surname></persName>
		</author>
		<idno type="DOI">10.1289/ehp.1104114</idno>
		<idno type="PMID">22645278</idno>
		<idno type="PMCID">PMC3440106</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3440106?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Health Perspectives</title>
		<title level="j" type="abbrev">Environmental Health Perspectives</title>
		<idno type="ISSN">0091-6765</idno>
		<idno type="ISSNe">1552-9924</idno>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1297" to="1300" />
			<date type="published" when="2012-09" />
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Bisphenol A levels in blood and urine in a Chinese population and the personal factors affecting the levels</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yonghua</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maohua</forename><surname>Miao</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Lisa</forename><forename type="middle">J</forename><surname>Herrinton</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Chunhua</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Wei</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhijun</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">De-Kun</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.envres.2009.04.003</idno>
		<idno type="PMID">19426969</idno>
	</analytic>
	<monogr>
		<title level="j">Environmental Research</title>
		<title level="j" type="abbrev">Environmental Research</title>
		<idno type="ISSN">0013-9351</idno>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="629" to="633" />
			<date type="published" when="2009-07" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Circulating Prolactin Associates With Diabetes and Impaired Glucose Regulation: A population-based study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Ning</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc12-1893</idno>
		<idno type="PMID">23340889</idno>
		<idno type="PMCID">PMC3687322</idno>
		<ptr type="open-access" target="https://care.diabetesjournals.org/content/diacare/36/7/1974.full.pdf" />
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<title level="j" type="abbrev">Diabetes Care</title>
		<idno type="ISSN">0149-5992</idno>
		<idno type="ISSNe">1935-5548</idno>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1974" to="1980" />
			<date type="published" when="2013-01-22" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Impaired Lung Function Is Associated with Increased Carotid Intima-Media Thickness in Middle-Aged and Elderly Chinese</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhimin</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yu</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yun</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Min</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaolin</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Huijie</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Baihui</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Fei</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Zhi</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoying</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Weiqing</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Yufang</forename><surname>Bi</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0053153</idno>
		<idno type="PMID">23457443</idno>
		<idno type="PMCID">PMC3574141</idno>
		<ptr type="open-access" target="https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0053153&amp;type=printable" />
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e53153</biblScope>
			<date type="published" when="2013-02-15" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Nonalcoholic Fatty Liver Disease Is Associated With Atherosclerosis in Middle-Aged and Elderly Chinese</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Bi</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><surname>Ning</surname></persName>
		</author>
		<idno type="DOI">10.1161/atvbaha.112.252957</idno>
		<idno type="PMID">22814750</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.112.252957" />
	</analytic>
	<monogr>
		<title level="j">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<title level="j" type="abbrev">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<idno type="ISSN">1079-5642</idno>
		<idno type="ISSNe">1524-4636</idno>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="2321" to="2326" />
			<date type="published" when="2012-07-19" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><forename type="middle">B</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">S</forename><surname>Siscovick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">A</forename><surname>Manolio</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Polak</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">L</forename><forename type="middle">P</forename><surname>Fried</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">N</forename><forename type="middle">O</forename><surname>Borhani</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">K</forename><surname>Wolfson</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.88.3.837</idno>
		<idno type="PMID">8353913</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.88.3.837" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="837" to="845" />
			<date type="published" when="1993-09" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Peripheral arterial disease in people with diabetes</title>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="3333" to="3341" />
			<date type="published" when="2003" />
			<publisher>American Diabetes Association</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Prevalence of and Risk Factors for Peripheral Arterial Disease in the United States: Results From the National Health and Nutrition Examination Survey, 1999-2000</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Selvin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">T</forename><forename type="middle">P</forename><surname>Erlinger</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.0000137913.26087.f0</idno>
		<idno type="PMID">15262830</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/01.CIR.0000137913.26087.F0" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="738" to="743" />
			<date type="published" when="2004-07-26" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Association of Urinary Bisphenol A Concentration with Heart Disease: Evidence from NHANES 2003/06</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">David</forename><surname>Melzer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Neil</forename><forename type="middle">E</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ceri</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">William</forename><forename type="middle">E</forename><surname>Henley</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Tamara</forename><forename type="middle">S</forename><surname>Galloway</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0008673</idno>
		<idno type="PMID">20084273</idno>
		<idno type="PMCID">PMC2800195</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<title level="j" type="abbrev">PLoS ONE</title>
		<idno type="ISSNe">1932-6203</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">e8673</biblScope>
			<date type="published" when="2010-01-13" />
			<publisher>Public Library of Science (PLoS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Exposure to Bisphenol A From Drinking Canned Beverages Increases Blood Pressure: Randomized Crossover Trial</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><surname>Bae</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y-C</forename><surname>Hong</surname></persName>
		</author>
		<idno type="DOI">10.1161/hypertensionaha.114.04261</idno>
		<idno type="PMID">25489056</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.114.04261" />
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<title level="j" type="abbrev">Hypertension</title>
		<idno type="ISSN">0194-911X</idno>
		<idno type="ISSNe">1524-4563</idno>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="313" to="319" />
			<date type="published" when="2014-12-08" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Bisphenol-A and the Great Divide: A Review of Controversies in the Field of Endocrine Disruption</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Laura</forename><forename type="middle">N</forename><surname>Vandenberg</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Maricel</forename><forename type="middle">V</forename><surname>Maffini</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Carlos</forename><surname>Sonnenschein</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Beverly</forename><forename type="middle">S</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Ana</forename><forename type="middle">M</forename><surname>Soto</surname></persName>
		</author>
		<idno type="DOI">10.1210/er.2008-0021</idno>
		<idno type="PMID">19074586</idno>
		<idno type="PMCID">PMC2647705</idno>
		<ptr type="open-access" target="https://academic.oup.com/edrv/article-pdf/30/1/75/8862892/edrv0075.pdf" />
	</analytic>
	<monogr>
		<title level="j">Endocrine Reviews</title>
		<title level="j" type="abbrev">Endocrine Reviews</title>
		<idno type="ISSN">0163-769X</idno>
		<idno type="ISSNe">1945-7189</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="75" to="95" />
			<date type="published" when="2009-02" />
			<publisher>The Endocrine Society</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Estrogen Signaling and Cardiovascular Disease</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Murphy</surname></persName>
		</author>
		<idno type="DOI">10.1161/circresaha.110.236687</idno>
		<idno type="PMID">21885836</idno>
		<idno type="PMCID">PMC3398381</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/CIRCRESAHA.110.236687" />
	</analytic>
	<monogr>
		<title level="j">Circulation Research</title>
		<title level="j" type="abbrev">Circulation Research</title>
		<idno type="ISSN">0009-7330</idno>
		<idno type="ISSNe">1524-4571</idno>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="687" to="696" />
			<date type="published" when="2011-09-01" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Estrogen Receptors and Endothelium</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J-F</forename><surname>Arnal</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><surname>Fontaine</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">A</forename><surname>Billon-Gales</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><surname>Favre</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">H</forename><surname>Laurell</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><surname>Lenfant</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Gourdy</surname></persName>
		</author>
		<idno type="DOI">10.1161/atvbaha.109.191221</idno>
		<idno type="PMID">20631350</idno>
		<ptr type="open-access" target="https://www.ahajournals.org/doi/pdf/10.1161/ATVBAHA.109.191221" />
	</analytic>
	<monogr>
		<title level="j">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<title level="j" type="abbrev">Arteriosclerosis, Thrombosis, and Vascular Biology</title>
		<idno type="ISSN">1079-5642</idno>
		<idno type="ISSNe">1524-4636</idno>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1506" to="1512" />
			<date type="published" when="2010-07-14" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Molecular and Cellular Basis of Cardiovascular Gender Differences</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">E</forename><surname>Mendelsohn</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">R</forename><forename type="middle">H</forename><surname>Karas</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1112062</idno>
		<idno type="PMID">15947175</idno>
		<ptr type="open-access" target="http://pdfs.semanticscholar.org/92eb/381fdc31bf53baeca6def2dd70bfc2afda92.pdf" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<title level="j" type="abbrev">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">308</biblScope>
			<biblScope unit="issue">5728</biblScope>
			<biblScope unit="page" from="1583" to="1587" />
			<date type="published" when="2005-06-10" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Estrogen receptor α is a major mediator of 17β-estradiol’s atheroprotective effects on lesion size in Apoe–/– mice</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jeffrey</forename><forename type="middle">B</forename><surname>Hodgin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">H</forename><surname>Krege</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Robert</forename><forename type="middle">L</forename><surname>Reddick</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kenneth</forename><forename type="middle">S</forename><surname>Korach</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Oliver</forename><surname>Smithies</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Nobuyo</forename><surname>Maeda</surname></persName>
		</author>
		<idno type="DOI">10.1172/jci11320</idno>
		<idno type="PMID">11160157</idno>
		<idno type="PMCID">PMC199197</idno>
		<ptr type="open-access" target="http://www.jci.org/articles/view/11320/files/pdf" />
	</analytic>
	<monogr>
		<title level="j">Journal of Clinical Investigation</title>
		<title level="j" type="abbrev">J. Clin. Invest.</title>
		<idno type="ISSN">0021-9738</idno>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="333" to="340" />
			<date type="published" when="2001-02-01" />
			<publisher>American Society for Clinical Investigation</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Abnormal Vascular Function and Hypertension in Mice Deficient in Estrogen Receptor beta</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Z</forename><surname>Bian</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><surname>Lu</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1065250</idno>
		<idno type="PMID">11799247</idno>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<idno type="ISSN">0036-8075</idno>
		<idno type="ISSNe">1095-9203</idno>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="issue">5554</biblScope>
			<biblScope unit="page" from="505" to="508" />
			<date type="published" when="2002-01-18" />
			<publisher>American Association for the Advancement of Science (AAAS)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Sex Differences in Coronary Heart Disease: Why Are Women So Superior? The 1995 Ancel Keys Lecture</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">E</forename><surname>Barrett-Connor</surname></persName>
		</author>
		<idno type="DOI">10.1161/01.cir.95.1.252</idno>
		<idno type="PMID">8994444</idno>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<title level="j" type="abbrev">Circulation</title>
		<idno type="ISSN">0009-7322</idno>
		<idno type="ISSNe">1524-4539</idno>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="252" to="264" />
			<date type="published" when="1997-01-07" />
			<publisher>Ovid Technologies (Wolters Kluwer Health)</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Hormone therapy to prevent disease and prolong life in postmenopausal women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Grady</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">M</forename><surname>Rubin</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><forename type="middle">B</forename><surname>Petitti</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">S</forename><surname>Fox</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">D</forename><surname>Black</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Ettinger</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><forename type="middle">L</forename><surname>Ernster</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">S</forename><forename type="middle">R</forename><surname>Cummings</surname></persName>
		</author>
		<idno type="DOI">10.1016/0020-7292(93)90679-q</idno>
		<idno type="PII">0020-7292(93)90679-Q</idno>
		<idno type="ark">ark:/67375/6H6-JK3FZZ95-2</idno>
		<idno type="istexId">886AC27FBA0166A32FC6822BC61F063B3A388225</idno>
	</analytic>
	<monogr>
		<title level="j">International Journal of Gynecology &amp; Obstetrics</title>
		<title level="j" type="abbrev">International Journal of Gynecology &amp; Obstetrics</title>
		<idno type="ISSN">0020-7292</idno>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="225" to="226" />
			<date type="published" when="1993-08" />
			<publisher>Wiley</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">91300401 Postmenopausal estrogen therapy and cardiovascular disease — Ten-year follow-up from the nurses&apos; health study</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">M</forename><forename type="middle">J</forename><surname>Stampfer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">G</forename><forename type="middle">A</forename><surname>Colditz</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">W</forename><forename type="middle">C</forename><surname>Willett</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">J</forename><forename type="middle">A E</forename><surname>Manson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">B</forename><surname>Rosner</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">F</forename><forename type="middle">E</forename><surname>Speizer</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">C</forename><forename type="middle">H</forename><surname>Hennekens</surname></persName>
		</author>
		<idno type="DOI">10.1016/0378-5122(92)90066-d</idno>
		<idno type="PII">0378-5122(92)90066-D</idno>
		<idno type="ark">ark:/67375/6H6-PZ27V40B-0</idno>
		<idno type="istexId">FE63E5CD7BA2CD2AD7B0D5D7C6BDEEDC05E7C313</idno>
	</analytic>
	<monogr>
		<title level="j">Maturitas</title>
		<title level="j" type="abbrev">Maturitas</title>
		<idno type="ISSN">0378-5122</idno>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="79" to="80" />
			<date type="published" when="1992-08" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Bisphenol A induces reactive oxygen species generation in the liver of male rats</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">V</forename><surname>Bindhumol</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">K</forename><forename type="middle">C</forename><surname>Chitra</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">P</forename><forename type="middle">P</forename><surname>Mathur</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0300-483x(03)00056-8</idno>
		<idno type="PMID">12767684</idno>
	</analytic>
	<monogr>
		<title level="j">Toxicology</title>
		<title level="j" type="abbrev">Toxicology</title>
		<idno type="ISSN">0300-483X</idno>
		<imprint>
			<biblScope unit="volume">188</biblScope>
			<biblScope unit="issue">2-3</biblScope>
			<biblScope unit="page" from="117" to="124" />
			<date type="published" when="2003-06" />
			<publisher>Elsevier BV</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Estrogen, aging and the cardiovascular system</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">James</forename><forename type="middle">P</forename><surname>Stice</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Jennifer</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Angela</forename><forename type="middle">S</forename><surname>Pechenino</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Anne</forename><forename type="middle">A</forename><surname>Knowlton</surname></persName>
		</author>
		<idno type="DOI">10.2217/14796678.5.1.93</idno>
		<idno type="PMID">19371207</idno>
		<idno type="PMCID">PMC3972065</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc3972065?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Future Cardiology</title>
		<title level="j" type="abbrev">Future Cardiology</title>
		<idno type="ISSN">1479-6678</idno>
		<idno type="ISSNe">1744-8298</idno>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="93" to="103" />
			<date type="published" when="2009-01" />
			<publisher>Future Medicine Ltd</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Temporal Variability and Predictors of Urinary Bisphenol A Concentrations in Men and Women</title>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Shruthi</forename><surname>Mahalingaiah</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><forename type="middle">D</forename><surname>Meeker</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Kimberly</forename><forename type="middle">R</forename><surname>Pearson</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Antonia</forename><forename type="middle">M</forename><surname>Calafat</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Xiaoyun</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">John</forename><surname>Petrozza</surname></persName>
		</author>
		<author>
			<persName xmlns="http://www.tei-c.org/ns/1.0"><forename type="first">Russ</forename><surname>Hauser</surname></persName>
		</author>
		<idno type="DOI">10.1289/ehp.10605</idno>
		<idno type="PMID">18288314</idno>
		<idno type="PMCID">PMC2235217</idno>
		<ptr type="open-access" target="http://europepmc.org/articles/pmc2235217?pdf=render" />
	</analytic>
	<monogr>
		<title level="j">Environmental Health Perspectives</title>
		<title level="j" type="abbrev">Environmental Health Perspectives</title>
		<idno type="ISSN">0091-6765</idno>
		<idno type="ISSNe">1552-9924</idno>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="173" to="178" />
			<date type="published" when="2008-02" />
			<publisher>Environmental Health Perspectives</publisher>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
